Legal Insights

< back to search results

FDA sets the stage for Cures Act breakthrough devices program in highly anticipated guidance document


On October 25, 2017, FDA released a critical draft guidance on the breakthrough medical device pathway established by the 21st Century Cures Act.

This briefing outlines the proposals.